Hexo

Hexo to close three facilities and lay off about 155 workers

Ottawa

Ottawa-based cannabis company says it will shutter properties in Kirkland Lake, Brantford and Stellarton, N.S., in a bid to streamline production.

Hexo auditor raises ‘substantial doubt’ about company as it reports Q4, fiscal 2021 losses

Ottawa

PricewaterhouseCoopers said its recent review of the Ottawa-based cannabis business showed that Hexo did not maintain effective internal control over financial reporting.

Hexo names food and beverage industry veteran Cooper new CEO

Ottawa

Move comes just two days after co-founder and former chief executive Sebastien St-Louis abruptly departed the Ottawa cannabis company.

Hexo CEO St-Louis out weeks after activist investor sounds alarm

Ottawa

Ottawa-based cannabis producer has seen its share price drop by 58 per cent since the beginning of the year.

Hexo shares wobble on Nasdaq debut

Ottawa

Cannabis firm’s shares hit a 2021 peak of US$10 on the NYSE in mid-February and have since fallen by 74 per cent.

Hexo stock plunges nearly 30% as Ottawa cannabis firm issues US$140M worth of new units

Ottawa

Company has been issuing new shares at a steady clip as it seeks to finance its ambitious expansion plans.

Hexo shifting to Nasdaq, adding marketing guru to C-suite as expansion drive ramps up

Ottawa

Cannabis producer is transferring its U.S. listing from the New York Stock Exchange in a move that’s expected to take effect next week.

Ottawa fintech firm Brane Capital unveils plans to go public on TSX Venture Exchange

Techopia

Company that’s aiming to become Canada’s first qualified custodian for cryptocurrency assets sees “huge opportunity” in emerging industry.

Cannabis company Hexo reports $20.7M Q3 loss, revenue edges higher

Ottawa

Ottawa-based firm’s net revenue totalled $22.7 million, up from $22.1 million in the same quarter last year.

Second class-action suit against Hexo dismissed in U.S. court

Ottawa

Ottawa firm was one of three major Canadian pot producers hit with lawsuits last year alleging they exaggerated or overestimated sales figures and market potential.